News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bayer HealthCare (BAY) Guilty of Breaching ABPI Codes



8/2/2012 7:22:22 AM

Bayer Healthcare has admitted to 12 breaches of the ABPI Code after one of its staff developed and distributed drug information without the company’s knowledge. In a highly embarrassing move, Bayer revealed that three documents relating to Bayer’s oral anticogulant Xarelto (rivaroxaban) were not submitted for review and certification (breaching clause 14.1). The first the company knew of the imbroglio was when a service improvement manager for an NHS heart and stroke network wrote to Bayer with her concerns about a proposal for joint working she had received.

Read at InPharm.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES